Meningioma
📧 Sign up to get email alerts when something new happens for Meningioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma [Phase 1, Phase 2]
A Phase 1/2 trial of RYZ101 for progressive or recurrent intracranial meningioma has been suspended.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Rare CNS Tumors Outcomes &Risk
A National Cancer Institute clinical trial update reports outcomes and risks for rare central nervous system tumors, including meningioma, e…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Re-bleeding in Giant Meningioma and Intraoperative Hydroxyethyl Starch (HES) Fluid Therapy
This clinical trial update reports on re-bleeding in patients with giant meningioma and discusses intraoperative hydroxyethyl starch (HES) f…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma [Phase 2]
Phase II study of 177Lu-DOTATATE in adults with progressive or high-risk meningioma is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC [Phase 2]
This Phase 2 clinical trial directly comparing Ga-68-DOTATATE and Ga-68-DOTATOC is studying meningioma and is currently not yet recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study [NA]
The HiPPI study is evaluating hypofractionated proton therapy for benign intracranial brain tumors and is currently recruiting. It targets m…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma [Phase 2]
An open-label Phase II trial updates results for nivolumab alone or in combination with ipilimumab in adults with progressive or recurrent m…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: MEningioma Detection Using Non Contrast MRI TecHniquEs
This clinical trial investigated non-contrast MRI techniques to detect meningioma. The study was terminated, and no results are reported in …
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
This clinical trial update reports on the concordance and accuracy of MRI in detecting meningiomas using optimized imaging sequences with lo…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent [Phase 2]
Phase 2 ascending-dose study of RVP-001, a manganese-based MRI contrast agent, completed to assess safety and preliminary efficacy in CNS le…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating REC-2282 in progressive NF2-mutated meningiomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Pharmacoscopy for Patients With Refractory Primary Brain Tumors [Phase 2]
Phase 2 clinical trial update for pharmacoscopy in patients with refractory primary brain tumors, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial [Phase 2]
This Phase IIc randomized feasibility pilot trial evaluated cognitive behavioral therapy for insomnia in patients with primary brain tumors …
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: 9-ING-41 in Pediatric Patients With Refractory Malignancies. [Phase 1]
Phase 1 trial of 9-ING-41 in pediatric patients with refractory malignancies was terminated; the update does not include study results.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Trabectedin for Recurrent Grade II/III Meningioma [Phase 2]
Phase 2 trial of trabectedin for recurrent grade II/III meningioma has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma [NA]
Clinical trial update on the Optune NovoTTF-100A device for recurrent atypical and anaplastic meningioma; the pilot study is active but not …
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Multicenter Evaluation in Patients With MEningiomas of the Response to Treatment With 177LUTEtium-oxodotreotide
A multicenter study evaluating the response of meningioma to treatment with lutetium-177 dotatate has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Embolization for Meningioma [NA]
A clinical trial is evaluating embolization as a treatment for meningioma and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors [Phase 1]
Phase 1 study evaluating panobinostat with stereotactic radiation therapy for brain tumors, including recurrent glioma, high-grade meningiom…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors [Phase 2]
Phase 2 trial of selumetinib in Neurofibromatosis type II–related tumors was terminated, with results posted in 2025; the study included ves…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection [NA]
Completed clinical trial evaluating the safety of intravenously administered tranexamic acid in patients undergoing supratentorial meningiom…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry
A completed clinical trial evaluates a semi-automatic segmentation method to determine tumor dosimetry for 177Lu-DOTATATE in meningioma. The…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma
A completed clinical trial evaluating the relationship between tumor absorbed dose and treatment response in meningioma patients treated wit…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma [Phase 2]
Phase II study of SYHA1813 for recurrent or progressive high-grade meningioma is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Proton Radiation For Meningiomas and Hemangiopericytomas [Phase 1, Phase 2]
Phase 1/2 trial update on proton radiation therapy for meningioma and hemangiopericytoma; the study has completed.